Pharma Pulse: Regional Cold Chain Disruptions and AstraZeneca Blueprint for Decarbonizing Supply Chain Heat

Mar 17, 10:00 AM

Headliner
Share
Subscribe
In today's Pharma Pulse, ongoing conflict in the Middle East disrupts critical pharmaceutical cold chains, while AstraZeneca and partners launch a new program to decarbonize industrial heat across global supply chains.
Share
Subscribe
Next
Pharma Pulse: FDA Expands Secukinumab Approval for Pediatric HS and Pharmacist-Led Testing Bridges Rural Care Gaps
Top episodes
Overcoming Supply Chain Challenges
by Pharmaceutical Commerce
Incorporating AI into Commercialization Plans
by Pharmaceutical Commerce
The Capabilities of a 3PL Provider
by Pharmaceutical Commerce